Compare Validfor's AI-native validation lifecycle platform (VLMS) with Valiqa, the self-serve AI-native validation platform. See how they differ in how you buy, speed, scope, and Part 11 lifecycle.
Validfor is a full AI-native, agentic validation lifecycle platform for life sciences, and its AI does generate validation protocols, reports, and documentation, so both platforms generate. Valiqa is the self-serve alternative: public $149/mo pricing, a first protocol in minutes, no demo, equipment-spec-first generation, and its own Part 11 lifecycle, e-signatures, a hash-chained audit trail, and deviation management, already built in. Validfor is demo-gated with no public pricing, and it still leads on deeper guided execution at scale and continuous compliance monitoring across a full agentic lifecycle.
Validfor is an AI-native, agentic validation platform for life sciences. Its AI generates validation protocols, reports, and documentation, and the platform manages the full lifecycle, change, deviation, test, and periodic review management, plus electronic signature and electronic records, working from system requirements and continuous change monitoring.
Large, regulated life-sciences enterprises that want an agentic platform continuously monitoring compliance and change across the full validation lifecycle, and that have the budget and timeline for a demo-gated enterprise rollout.
Valiqa is a self-serve, AI-native validation platform. It generates audit-ready IQ, OQ, PQ, DQ, PPQ, and other protocols from your equipment specifications, and adds Part 11 e-signatures, a hash-chained audit trail, deviation management, protocol versioning, and a conversational AI advisor.
Mid-market manufacturers (10-500 employees) that want audit-ready validation, from generation through e-signed and audited approval, without an enterprise sales cycle or a six-figure implementation.
Self-serve with transparent public pricing from $149/mo and an instant free trial; Validfor is demo-gated with no public pricing.
Minutes to your first protocol, equipment-spec-first, rather than starting from system requirements and continuous monitoring configuration.
A full Part 11 lifecycle built in: e-signatures (WebAuthn), a hash-chained audit trail, deviation management, and protocol versioning, not a separate module or add-on.
Valiqa Advisor: a conversational AI agent that scopes what each asset needs and answers grounded in your own validation data.
Learns your company's document format from a single uploaded example, and grounds each protocol in your uploaded equipment SOPs and manuals.
Breadth: 20+ regulations across medical devices, pharma, biotech, and food, plus a gap assessor, regulation matrix, and inspection-ready package export.
| Dimension | Valiqa | Validfor |
|---|---|---|
How you buy | Self-serve, public $149+/mo, instant free trial | Book a demo |
Time to first protocol | Minutes | Weeks to months |
Generates protocol content | ✓ | ✓ |
Input model | Equipment specs (make/model/params) | System requirements, continuous monitoring |
Part 11 lifecycle (e-sig, audit trail, deviations) | ✓ | ✓ |
Guided electronic execution (run protocols step-by-step in-app) Valiqa captures executed results under Part 11 controls | ◐ | ✓ |
Scope | AI-native validation platform (generation + Part 11 lifecycle) | Full AI-native lifecycle platform |
Target company size | Mid-market (10-500) | Enterprise / large |
Standards coverage | 20+ across med device, pharma, biotech, food | Pharma / life sciences |
Full agentic lifecycle: change, deviation, test, and periodic review management, plus continuous compliance monitoring across the validation lifecycle.
Electronic signature and electronic records built into the same agentic platform.
VC-backed enterprise platform targeting leading life-sciences enterprises.
Deeper guided electronic execution at scale: operators run protocols step-by-step in-app as the live system-of-record. (Valiqa captures executed results under Part 11 controls but does not offer the full guided execution experience.)
Valiqa is not affiliated with Validfor. All trademarks belong to their respective owners. Comparison based on publicly available information as of July 2026.
We use essential cookies for authentication and security. With your consent, we also use Microsoft Clarity on our marketing pages to understand how visitors navigate the site. Learn more.